Chemical Component Summary

Identifiers [(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl (2R,3S,4S)-5-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)-2,3,4-trihydroxypentyl dihydrogen diphosphate (non-preferred name)
[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl [[(2R,3S,4S)-5-(7,8-dimethyl-2,4-dioxo-benzo[g]pteridin-10-yl)-2,3,4-trihydroxy-pentoxy]-hydroxy-phosphoryl] hydrogen phosphate
Formula C27 H33 N9 O15 P2
Molecular Weight 785.55 g/mol
Type non-polymer
Isomeric SMILES Cc1cc2nc3c(nc(=O)[nH]c3=O)n(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n3cnc4c(N)ncnc34)c2cc1C
InChI InChI=1S/C27H33N9O15P2/c1-10-3-12-13(4-11(10)2)35(24-18(32-12)25(42)34-27(43)33-24)5-14(37)19(39)15(38)6-48-52(44,45)51-53(46,47)49-7-16-20(40)21(41)26(50-16)36-9-31-17-22(28)29-8-30-23(17)36/h3-4,8-9,14-16,19-21,26,37-41H,5-7H2,1-2H3,(H,44,45)(H,46,47)(H2,28,29,30)(H,34,42,43)/t14-,15+,16+,19-,20+,21+,26+/m0/s1

Chemical Details

Formal Charge 0
Atom Count 86
Chiral Atom Count 9
Chiral Atoms PA C4B C3B C2B C1B C2' C3' C4' P
Bond Count 91
Aromatic Bond Count 16

Drug Info: DrugBank

DrugBank ID DB03147   (Stereoisomeric match)
Name Flavin adenine dinucleotide
Groups approved
Description A condensation product of riboflavin and adenosine diphosphate. The coenzyme of various aerobic dehydrogenases, e.g., D-amino acid oxidase and L-amino acid oxidase. (Lehninger, Principles of Biochemistry, 1982, p972) Flavin adenine dinucleotide is approved for use in Japan under the trade name Adeflavin as an ophthalmic treatment for vitamin B2 deficiency.
  • Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine
  • Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]
  • FAD
  • Flavin adenine dinucleotide
  • FLAVIN-adenine dinucleotide
Salts Flavin adenine dinucleotide sodium
Brand Names
  • Enbrace Hr
  • Enlyte
  • Adeflavin
  • Flaziren
Affected Organism Humans and other mammals
Indication Used to treat eye diseases caused by vitamin B2 deficiency, such as keratitis and blepharitis.
Route of administration Oral
  • Adenine Nucleotides
  • Biological Factors
  • Carbohydrates
  • Coenzymes
  • Enzymes and Coenzymes
CAS number 146-14-5
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID: 21059682